D
Vaxil Bio Ltd. VXLLD
$0.12 $0.000.00% OTC PK
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 65.69% -36.64% -41.37% -163.00% -37.60%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 69.92% -62.12% -53.46% -117.88% -76.90%
Operating Income -69.92% 62.12% 53.46% 117.88% 76.90%
Income Before Tax -71.77% 62.12% 53.46% 114.98% 80.38%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -71.77% 62.12% 53.46% 114.98% 80.38%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -71.77% 62.12% 53.46% 114.98% 80.38%
EBIT -69.92% 62.12% 53.46% 117.88% 76.90%
EBITDA -- -- -- 118.20% 77.28%
EPS Basic -72.37% 62.03% 53.41% 115.05% 80.46%
Normalized Basic EPS -46.43% 62.04% 53.55% 117.87% 76.95%
EPS Diluted -72.37% 62.03% 53.41% 115.05% 80.46%
Normalized Diluted EPS -46.43% 62.04% 53.55% 117.87% 76.95%
Average Basic Shares Outstanding 0.00% 0.00% 0.00% 0.00% 0.00%
Average Diluted Shares Outstanding 0.00% 0.00% 0.00% 0.00% 0.00%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --